T1	Participants 77 119	patients with breast and colorectal cancer
T2	Participants 532 591	patients with cancer during adjuvant chemotherapy treatment
T3	Participants 827 919	patients with breast cancer (BRCA) and colorectal cancer (CRC) during adjuvant chemotherapy.
